研究文章
抗菌素耐药性的Enterobacterales细菌从血液分离波兰医院的外科感染病人
表2
耐药Enterobacterales杆菌在外科病房进行了研究。
|
|
Enterobacterales n= 121 (100%) |
| Nr的类别 |
抗菌药物类别 |
抗微生物剂 |
大肠杆菌n= 74 (61.1%) |
克雷伯氏菌spp。n= 33(27.2%) |
其他人n= 14 (11.5%) |
|
| 1 |
青霉素,青霉素抑制剂 |
氨苄青霉素 |
73例(98.6%) |
33 (100%) |
14 (100%) |
| Ampicillin-sulbactam |
72例(97.2%) |
33 (100%) |
13 (92.8%) |
| Amoxicillin-clavulanic酸 |
34 (45.9%) |
20 (60.6%) |
5 (35.7%) |
| Piperacillin-tazobactam |
10 (13.5%) |
11 (33.3%) |
3 (21.4%) |
|
| 2 |
头孢菌素 |
头孢呋辛四世 |
29 (39.1%) |
15 (45.4%) |
7 (50.0%) |
| 头孢他啶 |
29 (39.1%) |
14 (42.4%) |
5 (35.7%) |
| 头孢噻肟 |
28 (37.1%) |
13 (39.3%) |
5 (35.7%) |
| 头孢吡肟 |
22 (29.7%) |
16 (48.4%) |
5 (35.7%) |
| Cefoperazone-sulbactam |
6 (8.1%) |
6 (18.1%) |
0 |
|
| 3 |
碳青霉烯 |
厄他培南 |
0 |
1 (3.0%) |
0 |
| Imipenem |
1 (1.3%) |
0 |
0 |
| Meropenem |
0 |
0 |
0 |
|
| 4 |
氟喹诺酮类原料药 |
环丙沙星 |
36 (48.6%) |
24 (72.7%) |
8 (57.1%) |
|
| 5 |
氨基糖甙类 |
庆大霉素 |
19 (25.6%) |
7 (21.2%) |
5 (35.7%) |
| 阿米卡星 |
11 (14.8%) |
13 (39.3%) |
2 (14.2%) |
| 妥布霉素 |
24 (32.4%) |
17 (51.5%) |
5 (35.7%) |
|
| 6 |
其他人 |
功效 |
37 (50.0%) |
21 (63.6%) |
9 (64.2%) |
|
| ∗Nonsusceptible抗菌类别 |
0类别(完全敏感) |
0 |
0 |
0 |
| 1类 |
25 (33.7%) |
5 (15.1%) |
2 (14.2%) |
| 两类 |
15 (20.2%) |
6 (18.1%) |
3 (21.4%) |
| 3类 |
4 (5.4%) |
4 (12.1%) |
4 (28.5%) |
| 4个类别 |
11 (14.8%) |
4 (12.1%) |
1 (7.1%) |
| 5类 |
18 (24.3%) |
14 (42.4%) |
4 (28.5%) |
| 6类 |
1 (1.36%) |
0 |
0 |
|
|
菌株分为六类基于他们的抵抗特定数量的抗菌剂的分类(青霉素,青霉素抑制剂、头孢菌素、碳青霉烯氟喹诺酮类原料药,氨基糖甙类、甲氧苄氨嘧啶和);完全从所有类别所有抗菌药物敏感性意味着“0”;“6”是指抵抗至少一个从每个6类抗菌剂。
|
